Neurontin and Dissociative identity disorder - a phase IV clinical study of FDA data

Summary:

Dissociative identity disorder is found among people who take Neurontin, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Neurontin and have Dissociative identity disorder. It is created by eHealthMe based on reports of 98,366 people who have side effects when taking Neurontin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jun, 14, 2022

98,366 people reported to have side effects when taking Neurontin.
Among them, 7 people (0.01%) have Dissociative identity disorder.


What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 101,795 Neurontin users for its effectiveness, alternative drugs and more.

What is Dissociative identity disorder?

Dissociative identity disorder is found to be associated with 221 drugs and 118 conditions by eHealthMe.

Number of Neurontin and Dissociative identity disorder reports submitted per year:

Could Neurontin cause Dissociative identity disorder?

Gender of people who have Dissociative identity disorder when taking Neurontin *:

  • female: 50 %
  • male: 50 %

Age of people who have Dissociative identity disorder when taking Neurontin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Neurontin *:

  1. Zometa: 4 people, 57.14%
  2. Percocet: 4 people, 57.14%
  3. Combivir: 4 people, 57.14%
  4. Xalatan: 4 people, 57.14%
  5. Lisinopril: 4 people, 57.14%
  6. Ms Contin: 4 people, 57.14%
  7. Nulytely: 4 people, 57.14%
  8. Lamivudine: 4 people, 57.14%
  9. Abacavir: 4 people, 57.14%
  10. Viramune: 4 people, 57.14%

Common side effects people have besides Dissociative identity disorder *:

  1. Suicidal Ideation: 6 people, 85.71%
  2. Hypoaesthesia Oral (reduced sense of touch or sensation in mouth): 4 people, 57.14%
  3. Headache (pain in head): 4 people, 57.14%
  4. Emotional Distress: 4 people, 57.14%
  5. Fatigue (feeling of tiredness): 4 people, 57.14%
  6. Fear: 4 people, 57.14%
  7. Fistula Discharge (discharge from abnormal passage of structure/organ): 4 people, 57.14%
  8. Gums - Swollen: 4 people, 57.14%
  9. Infection: 4 people, 57.14%
  10. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 4 people, 57.14%

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 57.14%
  2. Bipolar Disorder (mood disorder): 3 people, 42.86%
  3. Burning Sensation: 2 people, 28.57%
  4. Quit Smoking: 1 person, 14.29%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 14.29%
  6. Depression: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and have Dissociative identity disorder?

Check whether Dissociative identity disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Dissociative identity disorder and when was it recovered:

Expand to all the drugs that have ingredients of gabapentin:

Alternative drugs to, pros and cons of Neurontin:

Common Neurontin side effects:

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dissociative identity disorder treatments and more:

COVID vaccines that are related to Dissociative identity disorder:

All the drugs that are associated with Dissociative identity disorder:

All the conditions that are associated with Dissociative identity disorder:

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: